Registry for Longitudinal Evaluation of Heart Transplanted Patients

February 20, 2026 updated by: Annalisa Turco, Fondazione IRCCS Policlinico San Matteo di Pavia
The overall objective of compiling this registry is to obtain a complete collection of data, in a dedicated database, on all patients who have undergone transplantation at our Center in order to assess the main causes of mortality, hospitalization, and morbidity.

Study Overview

Status

Completed

Conditions

Detailed Description

Secondary objective: the information acquired will enable us to review more appropriate outpatient management of these patients and redefine our internal management protocols in order to reduce morbidity, hospitalization, and mortality in these patients.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Italy
      • Pavia, Italy, 27100
        • Fondazione IRCCS Policlinico San Matteo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The objective of the registry is to have an up-to-date, high quality and exhaustive data collection for the evaluation of the overall survival in the population of heart transplanted recipients and the incidence of hearth, kidney, infectious complications over the last thirty years and their determinants.

Description

Inclusion Criteria:

-

To be included in the study the patient must:

  • Give written informed consent to participate for the prospective evaluations
  • Be a heart transplanted patient
  • Be aged 18 years and over

Exclusion Criteria:

  • Withdrawn of the consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall Mortality in Heart Transplant Recipients
Time Frame: After 1 month, 6 months, one year, and 5 years
The primary objective of this registry is to evaluate overall mortality of the cohort of heart transplanted patients at Fondazione IRCCS Policlinico San Matteo.
After 1 month, 6 months, one year, and 5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cause-Specific Mortality, Morbidity, and Hospitalization
Time Frame: After 1 month, 6 months, one year, and 5 years
The secondary objective is to evaluate the specific mortality, morbidity and hospitalization
After 1 month, 6 months, one year, and 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 28, 2018

Primary Completion (Actual)

December 29, 2023

Study Completion (Actual)

December 29, 2023

Study Registration Dates

First Submitted

December 5, 2025

First Submitted That Met QC Criteria

February 20, 2026

First Posted (Actual)

February 25, 2026

Study Record Updates

Last Update Posted (Actual)

February 25, 2026

Last Update Submitted That Met QC Criteria

February 20, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • P_60156

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Transplant

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe